House approves funding for a study on using psychedelic therapy for veterans

The House approved an amendment to the Department of Defense Appropriations bill Wednesday that would provide $15 million to the Defense Department to conduct medical clinical trials for veterans using psychedelics to treat traumatic brain injuries.
The amendment, introduced by Rep. Morgan Luttrell (R-TX), would fund and allow DOD service branches to create research-based studies on using psychedelics to treat veterans with cognitive deficiencies, such as traumatic brain injuries, post-traumatic stress, and post-traumatic stress disorder.
UAW STRIKE: FOUR-DAY WORKWEEK FAVORED BY UNION GAINING IN POPULARITY
“Our primary go-to is opioids or selective serotonin reuptake inhibitors, and we are steadily digging an endless hole for veterans that they’ll fall down in, and it’s very difficult to climb out that. The addiction rates are astronomical,” Luttrell told the Washington Examiner. “So if we can replace opioids, SSRIs, and other pharmaceuticals that are in place to treat these issues with something that’s a shorter term address that creates sustainable long term positive effects, that’s a win across the board.”
Luttrell, a former Navy SEAL, has his own personal story with psychedelic therapy.
During his service, he had suffered multiple traumatic brain injuries, he said, and when he returned, he had trouble …